- Home
- ABCL vs RERE Comparison
ABCL vs RERE Comparison
Compare ABCL & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCL
- RERE
- Stock Information
- Founded
- ABCL 2012
- RERE 2011
- Country
- ABCL Canada
- RERE China
- Employees
- ABCL N/A
- RERE N/A
- Industry
- ABCL Biotechnology: Pharmaceutical Preparations
- RERE Other Specialty Stores
- Sector
- ABCL Health Care
- RERE Consumer Discretionary
- Exchange
- ABCL Nasdaq
- RERE Nasdaq
- Market Cap
- ABCL 818.2M
- RERE 678.4M
- IPO Year
- ABCL 2020
- RERE 2021
- Fundamental
- Price
- ABCL $2.42
- RERE $2.14
- Analyst Decision
- ABCL Buy
- RERE
- Analyst Count
- ABCL 3
- RERE 0
- Target Price
- ABCL $7.50
- RERE N/A
- AVG Volume (30 Days)
- ABCL 4.1M
- RERE 1.0M
- Earning Date
- ABCL 05-08-2025
- RERE 05-19-2025
- Dividend Yield
- ABCL N/A
- RERE N/A
- EPS Growth
- ABCL N/A
- RERE N/A
- EPS
- ABCL N/A
- RERE N/A
- Revenue
- ABCL $28,833,000.00
- RERE $2,237,042,920.00
- Revenue This Year
- ABCL N/A
- RERE $29.57
- Revenue Next Year
- ABCL $27.77
- RERE $24.43
- P/E Ratio
- ABCL N/A
- RERE N/A
- Revenue Growth
- ABCL N/A
- RERE 25.93
- 52 Week Low
- ABCL $1.89
- RERE $1.53
- 52 Week High
- ABCL $4.34
- RERE $3.70
- Technical
- Relative Strength Index (RSI)
- ABCL 52.58
- RERE 26.24
- Support Level
- ABCL $1.89
- RERE $2.12
- Resistance Level
- ABCL $2.53
- RERE $2.40
- Average True Range (ATR)
- ABCL 0.19
- RERE 0.21
- MACD
- ABCL 0.05
- RERE -0.06
- Stochastic Oscillator
- ABCL 82.79
- RERE 2.11
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.